Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
2001

Kirsten ras mutations in colorectal cancer

Sample size: 3439 publication Evidence: high

Author Information

Author(s): Andreyev H J N, Norman A R, Cunningham D, Oates J, Dix B R, Iacopetta B J, Young J, Walsh T, Ward R, Hawkins N, Beranek M, Jandik P, Benamouzig R, Jullian E, Laurent-Puig P, Olschwang S, Muller O, Hoffmann I, Rabes H M, Zietz C, Troungos C, Valavanis C, Yuen S T, Ho J W C, Croke C T, O'Donoghue D P, Giaretti W, Rapallo A, Russo A, Bazan V, Tanaka M, Omura K, Azuma T, Ohkusa T, Fujimori T, Ono Y, Pauly M, Faber C, Glaesener R, Goeij A F P M de, Arends J W, Andersen S N, Lövig T, Breivik J, Gaudernack G, Clausen O P F, Angelis P De, Meling G I, Rognum T O, Smith R, Goh H-S, Font A, Rosell R, Sun X F, Zhang H, Benhattar J, Losi L, Lee J Q, Wang S T, Clarke P A, Bell S, Quirke P, Bubb V J, Piris J, Cruickshank N R, Morton D, Fox J C, Al-Mulla F, Lees N, Hall C N, Snary D, Wilkinson K, Dillon D, Costa J, Pricolo V E, Finkelstein S D, Thebo J S, Senagore A J, Halter S A, Wadler S, Malik S, Krtolica K, Urosevic N

Primary Institution: Department of Medicine & Therapeutics, Imperial College School of Medicine, Chelsea & Westminster Hospital, London, UK

Hypothesis

Do different Kirsten ras mutations affect the outcomes of colorectal cancer patients?

Conclusion

The study found that a specific mutation in the Kirsten ras gene significantly impacts survival outcomes in colorectal cancer patients.

Supporting Evidence

  • The study analyzed data from 3439 patients after applying exclusion criteria.
  • Only one mutation on codon 12 had a statistically significant impact on survival.
  • The glycine to valine mutation was found in 8.6% of patients.
  • This mutation had a greater impact on patients with Dukes’ C cancers compared to Dukes’ B tumours.

Takeaway

This study looked at how certain gene changes in cancer can affect how well patients do. One specific change was found to be really important for survival.

Methodology

Data from 3439 patients were analyzed using multivariate analysis to assess the impact of Kirsten ras mutations on survival.

Participant Demographics

Patients from 42 centres in 21 countries were included.

Statistical Information

P-Value

P = 0.004

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1054/bjoc.2001.1964

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication